| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
a Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland
b Division of Cardiology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland
Accepted for publication August 6, 2009.
* Address correspondence to Dr Conte, Johns Hopkins Hospital, Blalock 618, 600 N Wolfe St, Baltimore, MD 21287 (Email: jconte{at}csurg.jhmi.jhu.edu).
Presented at the Poster Session of the Forty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Francisco, CA, Jan 26–28, 2009.
Background: The Leitz-Miller (LM), Columbia (COL), Acute Physiology and Chronic Health Evaluation II (APACHE II), Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS), and Seattle Heart Failure Model (SHFM) risk scores have been used to risk stratify patients with pulsatile-flow left ventricular assist devices (LVAD). We assessed the predictive ability of these scores in a cohort of continuous-flow LVAD patients.
Methods: Preoperative scores were calculated from prospective data of patients who received continuous-flow LVADs between June 2000 and May 2009. Cox proportional hazard analysis assessed the effect of preoperative variables and scores on 30-day, 90-day, and 1-year mortality. Patients were stratified by score into low- and high-risk groups. Survival was modeled using the Kaplan-Meier method.
Results: During the study period, 86 continuous-flow LVADs were implanted. The mean (± standard deviation) preoperative scores were: COL, 1.05 ± 1.59; LM, 11.9 ± 5.4; APACHE II, 15.6 ± 4.3; INTERMACS, 2.64 ± 1.01; and SHFM, 2.97 ± 1 .42. On univariate analysis, the SHFM score best differentiated low- and high-risk patients at all mortality end points; the INTERMACS and APACHE II scores were predictive for 90-day and 1-year mortality. On multivariable analysis, SHFM (hazard ratio [HR], 1.50; 95% confidence interval [CI], 1.02 to 2.21; p = 0.04) and APACHE II (HR, 1.10; 95% CI, 1.01 to 1.21; p = 0.04) predicted 1-year mortality.
Conclusions: Among the LM, COL, APACHE II, INTERMACS, and SHFM scores, the best predictor of mortality in a single institutional cohort of continuous-flow LVAD patients was the SHFM score.
This article has been cited by other articles:
|
|
 |
|
  B. Worku, Y. Naka, S.-W. Pak, F. H. Cheema, O. T. Siddiqui, J. Jain, N. Uriel, R. Bhatt, P. Colombo, U. Jorde, et al. Predictors of Mortality After Short-Term Ventricular Assist Device Placement Ann. Thorac. Surg., November 1, 2011; 92(5): 1608 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Adamson, M. Stahovich, S. Chillcott, S. Baradarian, J. Chammas, B. Jaski, P. Hoagland, and W. Dembitsky Clinical Strategies and Outcomes in Advanced Heart Failure Patients Older Than 70 Years of Age Receiving the HeartMate II Left Ventricular Assist Device: A Community Hospital Experience J. Am. Coll. Cardiol., June 21, 2011; 57(25): 2487 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Owens and M. Jessup The Year in Heart Failure J. Am. Coll. Cardiol., April 12, 2011; 57(15): 1573 - 1583. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Schaffer, G. J. Arnaoutakis, J. G. Allen, E. S. Weiss, N. D. Patel, S. D. Russell, A. S. Shah, and J. V. Conte Bleeding Complications and Blood Product Utilization With Left Ventricular Assist Device Implantation Ann. Thorac. Surg., March 1, 2011; 91(3): 740 - 749. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
